Buscar
Mostrando ítems 21-30 de 1247
Development of anti-SARS-CoV-2 specific scFv antibody library from convalescent plasma of COVID-19 recovered patients using phage display technology
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2021)
SARS-CoV-2 S1, S2, M & N antigens expressed in Pichia pastoris: Affordable, safe & effective vaccine for developing countries
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2021)
Inactivated SARS-CoV-2 for safe use in analytical and non-clinical trials
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2022)
Selection of aptamers which binds human ACE-2 (angiotensin converting enzyme) for blocking RBD (receptor-binding domain) of SARS-CoV-2 protein S
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2022)
Household clustering of SARS-CoV-2 in community settings: A study from rural ecuador
(American Society of Tropical Medicine and Hygiene, 2020)
The SARS-CoV-2 pandemic is now expanding into the developing world with devastating consequences. Departing from a population-based study in rural Ecuador where all adult individuals (aged 40 years or older) were tested ...
Cuantificación del desplazamiento del terreno en una zona de explotación minera mediante Interferometría Diferencial SAR
(Riobamba, Universidad Nacional de Chimborazo, 2021)
Immunoinformatic identifcation of B cell and T cell epitopes in the SARS‐CoV‐2 proteome
A novel coronavirus (SARS-CoV-2) emerged from China in late 2019 and rapidly spread across the
globe, infecting millions of people and generating societal disruption on a level not seen since the
1918 infuenza pandemic. ...
Revised interpretation of recent InSAR signals observed at Llaima volcano (Chile)
(AMER GEOPHYSICAL UNION, 2015)
El potencial de la nanotecnología para evitar que el SARS-Cov-2 ingrese a nuestro organismo.Nanotechnology’s potential to prevent that SARS-CoV-2 enters our organism
(Pontificia Universidad Católica del PerúPE, 2021)